legal-news

2:26-cv-01190 REGENXX TECHNOLOGIES, LLC v. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.

26-cv-01190 Filed
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

Regenxx Technologies, LLC has initiated litigation against the Musculoskeletal Transplant Foundation, Inc. The recent docket entry concerns the filing of a Corporate Disclosure Statement by counsel, a routine procedural requirement to disclose any parent companies or publicly held entities with a financial interest in the litigation. No substantive claims or defenses are detailed.

Stage

Active litigation

Timeline

1 event

Coverage

1 article

Sources

1

Key Issues

  • Corporate disclosure
  • Litigation parties
  • Procedural compliance
Advertisement

Case Timeline

1 event
info
Other April 13, 2026

2:26-cv-01190 REGENXX TECHNOLOGIES, LLC v. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.

In the case between REGENXX TECHNOLOGIES, LLC and MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC., a Corporate Disclosure Statement was filed by the attorney. This document provides information about the parties' corporate affiliations and financial interests to ensure transparency in the litigation process.

Advertisement
newspaper

Press Coverage

1 article